Human miR-221/222 in physiological and atherosclerotic vascular remodeling

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Chistiakov, Dmitry A ^a,b   Sobenin, Igor A ^c,d   Orekhov, Alexander N ^c,e   Bobryshev, Yuri V ^c,f,g  

^a PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^b Mount Sinai Comprehensive Cancer Center   (United States)

^c INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^d INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^e Institute for Atherosclerosis Research   (Russian Federation)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA 221; MICRORNA 222; MICRORNA; MIRN221 MICRORNA, HUMAN; MIRN222 MICRORNA, HUMAN;

ADIPOSE TISSUE; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ATHEROSCLEROSIS; BIOGENESIS; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELL MOTILITY; CELL POPULATION; CHRONIC INFLAMMATION; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; GENE FUNCTION; GLUCOSE METABOLISM; HUMAN; LIVER; NEOINTIMA; PHENOTYPIC PLASTICITY; PHYSIOLOGY; REVIEW; SKELETAL MUSCLE; UPREGULATION; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE CELL; GENE SILENCING; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; RISK FACTOR;

ATHEROSCLEROSIS; BASE SEQUENCE; GENE SILENCING; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; RISK FACTORS; VASCULAR REMODELING;

EID: 84937020051     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/354517     Document Type: Review

References (204)

1. M. K. Pugsley and R. Tabrizchi, "The vascular system: an overview of structure and function," Journal of Pharmacological and Toxicological Methods, vol. 44, no. 2, pp. 333-340, 2000.
2. M. Lannoy, S. Slove, and M. P. Jacob, "The function of elastic fibers in the arteries: beyond elasticity," Pathologie Biologie, vol. 62, no. 2, pp. 79-83, 2014.
3. V. A. Korshunov, S. M. Schwartz, and B. C. Berk, "Vascular remodeling: hemodynamic and biochemical mechanisms underlying Glagov's phenomenon," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 8, pp. 1722-1728, 2007.
4. D. B. Cowan and B. L. Langille, "Cellular andmolecular biology of vascular remodeling," Current Opinion in Lipidology, vol. 7, no. 2, pp. 94-100, 1996.
5. S. Gerecht-Nir, S. Osenberg, O. Nevo, A. Ziskind, R. Coleman, and J. Itskovitz-Eldor, "Vascular development in early human embryos and in teratomas derived fromhuman embryonic stem cells," Biology of Reproduction, vol. 71, no. 6, pp. 2029-2036, 2004.
6. J. L. Lucitti, E. A. V. Jones, C. Huang, J. Chen, S. E. Fraser, and M. E. Dickinson, "Vascular remodeling of the mouse yolk sac requires hemodynamic force," Development, vol. 134, no. 18, pp. 3317-3326, 2007.
7. M. D. Garcia and I. V. Larina, "Vascular development and hemodynamic force in the mouse yolk sac," Frontiers in Physiology, vol. 5, article 308, 2014.
8. E. Tzima, M. Irani-Tehrani, W. B. Kiosses et al., "Amechanosensory complex thatmediates the endothelial cell response to fluid shear stress," Nature, vol. 437, no. 7057, pp. 426-431, 2005.
9. D. E. Conway, M. T. Breckenridge, E. Hinde, E. Gratton, C. S. Chen, and M. A. Schwartz, "Fluid shear stress on endothelial cells modulates mechanical tension across VE-cadherin and PECAM-1," Current Biology, vol. 23, no. 11, pp. 1024-1030, 2013.
10. L.Robb, I. Lyons, R. Li et al., "Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene," Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 15, pp. 7075-7079, 1995.
11. N. Matsumoto, A. Kubo, H. Liu et al., "Developmental regulation of yolk sac hematopoiesis by Krüppel-like factor 6," Blood, vol. 107, no. 4, pp. 1357-1365, 2006.
12. N. Krankel, T. F. Luscher, and U. Landmesser, "Novel insights into vascular repair mechanisms," Current Pharmaceutical Design, vol. 20, no. 14, pp. 2430-2438, 2014.
13. M. Li, S. Li, L. Yu et al., "Bone mesenchymal stem cells contributed to the neointimal formation after arterial injury," PLoS ONE, vol. 8, no. 12, Article IDe82743, 2013.
14. A. K. Wara, A. Manica, J. F. Marchini et al., "Bone marrowderived kruppel-like factor 10 controls reendothelialization in response to arterial injury," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 7, pp. 1552-1560, 2013.
15. K. R. Stenmark, M. E. Yeager, K. C. El Kasmi et al., "The adventitia: essential regulator of vascular wall structure and function," Annual Review of Physiology, vol. 75, pp. 23-47, 2013.
16. A.N. Orekhov, Y.V. Bobryshev, and D. A. Chistiakov, "The complexity of cell composition of the intima of large arteries: focus on pericyte-like cells," Cardiovascular Research, vol. 103, no. 4, pp. 438-451.
17. P. Libby, P. M. Ridker, and G. K. Hansson, "Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice," Journal of the American College of Cardiology, vol. 54, no. 23, pp. 2129-2138, 2009.
18. P. Libby, A. Lichtman, and G. Hansson, "Immune effector mechanisms implicated in atherosclerosis: from mice to humans," Immunity, vol. 38, no. 6, pp. 1092-1104, 2013.
19. S. Glagov, E. Weisenberg, C. K. Zarins, R. Stankunavicius, and G. J. Kolettis, "Compensatory enlargement of human atherosclerotic coronary arteries," The New England Journal of Medicine, vol. 316, no. 22, pp. 1371-1375, 1987.
20. S. Lim and S. Park, "Role of vascular smooth muscle cell in the inflammation of atherosclerosis," BMB Reports, vol. 47, no. 1, pp. 1-7, 2014.
21. P. Puddu, A. Muscari, G. M. Puddu, E. Cravero, C. Giannoni, and M. Zoli, "The complexity of platelet metabolism and its contribution to atherothrombosis," Acta Cardiologica, vol. 64, no. 2, pp. 157-165, 2009.
22. F. Xu, Y. Sun, Y. Chen et al., "Endothelial cell apoptosis is reponsible for the formation of coronary thrombotic atherosclerotic plaques," Tohoku Journal of ExperimentalMedicine, vol. 218, no. 1, pp. 25-33, 2009.
23. F. Otsuka, K. Sakakura, K. Yahagi, M. Joner, and R. Virmani, "Has our understanding of calcification in human coronary atherosclerosis progressed?" Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 4, pp. 724-736, 2014.
24. Y. Wei, A. Schober, and C. Weber, "Pathogenic arterial remodeling: the good and bad of microRNAs," American Journal of Physiology: Heart and Circulatory Physiology, vol. 304, no. 8, pp. H1050-H1059, 2013.
25. L. Poliseno, A. Tuccoli, L. Mariani et al., "MicroRNAs modulate the angiogenic properties of HUVECs," Blood, vol. 108, no. 9, pp. 3068-3071, 2006.
26. B. N. Davis, A. C. Hilyard, P. H. Nguyen, G. Lagna, and A. Hata, "Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype," Journal of Biological Chemistry, vol. 284, no. 6, pp. 3728-3738, 2009.
27. A. Kuehbacher, C. Urbich, and S. Dimmeler, "Targeting microRNAexpression to regulate angiogenesis," Trends in Pharmacological Sciences, vol. 29, no. 1, pp. 12-15, 2008.
28. S. Albinsson and W. C. Sessa, "Can microRNAs control vascular smooth muscle phenotypic modulation and the response to injury?" Physiological Genomics, vol. 43, no. 10, pp. 529-533, 2011.
29. Z. Song and G. Li, "Role of specificMicroRNAs in regulation of vascular smooth muscle cell differentiation and the response to injury," Journal of Cardiovascular Translational Research, vol. 3, no. 3, pp. 246-250, 2010.
30. C. Rippe, M. Blimline, K.A. Magerko et al., "MicroRNAchanges in human arterial endothelial cells with senescence: relation to apoptosis, eNOS and inflammation," Experimental Gerontology, vol. 47, no. 1, pp. 45-51, 2012.
31. P. K. Santhekadur, S. K. Das, R. Gredler et al., "Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221,"The Journal of Biological Chemistry, vol. 287, no. 17, pp. 13952-13958, 2012.
32. N. Zhu, D. Zhang, S. Chen et al., "Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration," Atherosclerosis, vol. 215, no. 2, pp. 286-293, 2011.
33. T. Ogawa, M. Enomoto, H. Fujii et al., "MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis," Gut, vol. 61, no. 11, pp. 1600-1609, 2012.
34. N. C. Mackenzie, K. A. Staines, D. Zhu, P. Genever, and V. E. Macrae, "miRNA-221 and miRNA-222 synergistically function to promote vascular calcification," Cell Biochemistry and Function, vol. 32, no. 2, pp. 209-216, 2014.
35. C. Wang, S. Wang, P. Zhao et al., "MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression," Journal of Cellular Biochemistry, vol. 113, no. 6, pp. 2040-2046, 2012.
36. W. Jin, M. A. Reddy, Z. Chen et al., "Small RNA sequencing reveals MicroRNAs that modulate angiotensin II effects in vascular smooth muscle cells," Journal of Biological Chemistry, vol. 287, no. 19, pp. 15672-15683, 2012.
37. Y. Li, Y.-H. Song, F. Li, T. Yang, Y. W. Lu, and Y.-J. Geng, "microRNA-221 regulates high glucose-induced endothelial dysfunction," Biochemical and Biophysical Research Communications, vol. 381, no. 1, pp. 81-83, 2009.
38. G. di Leva, P. Gasparini, C. Piovan et al., "MicroRNA cluster 221-222 and estrogen receptor α interactions in breast cancer," Journal of the National Cancer Institute, vol. 102, no. 10, pp. 706-721, 2010.
39. A. Leung, C. Trac, W. Jin et al., "Novel long noncoding RNAs are regulated by angiotensin II in vascular smoothmuscle cells," Circulation Research, vol. 113, no. 3, pp. 266-278, 2013.
40. M. Landthaler, A. Yalcin, and T. Tuschl, "The human DiGeorge syndrome critical region gene 8 and its D. melanogaster homolog are required for miRNA biogenesis," Current Biology, vol. 14, no. 23, pp. 2162-2167, 2004.
41. M. T. Bohnsack, K. Czaplinski, and D. Görlich, "Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs," RNA, vol. 10, no. 2, pp. 185-191, 2004.
42. T. P. Chendrimada, R. I. Gregory, E. Kumaraswamy et al., "TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing," Nature, vol. 436, no. 7051, pp. 740-744, 2005.
43. V. N. Kim, "MicroRNA biogenesis: coordinated cropping and dicing," Nature Reviews Molecular Cell Biology, vol. 6, no. 5, pp. 376-385, 2005.
44. B. Yao, S. Li, and E. K. L. Chan, "Function of GW182 and GW bodies in siRNA and miRNA pathways," Advances in Experimental Medicine and Biology, vol. 768, pp. 71-96, 2013.
45. J. Yang, T. Välineva, J. Hong et al., "Transcriptional co-activator protein p100 interacts with snRNP proteins and facilitates the assembly of the spliceosome,"Nucleic Acids Research, vol. 35, no. 13, pp. 4485-4494, 2007.
46. X. Meng, K. W. Thiel, and K. K. Leslie, "Drug resistance mediated by AEG-1/MTDH/LYRIC," Advances in Cancer Research, vol. 120, pp. 135-157, 2013.
47. A. Khvorova, A. Reynolds, and S. D. Jayasena, "Functional siRNAs and miRNAs exhibit strand bias," Cell, vol. 115, no. 2, pp. 209-216, 2003.
48. M. Kulkarni, S. Ozgur, and G. Stoecklin, "On track with Pbodies," Biochemical Society Transactions, vol. 38, no. 1, pp. 242-251, 2010.
49. G. L. Sen and H. M. Blau, "Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies," Nature Cell Biology, vol. 7, no. 6, pp. 633-636, 2005.
50. L.-A. MacFarlane and P. R. Murphy, "MicroRNA: biogenesis, function and role in cancer," Current Genomics, vol. 11, no. 7, pp. 537-561, 2010.
51. J. Brennecke, A. Stark, R. B. Russell, and S. M. Cohen, "Principles of microRNA-target recognition," PLoS Biology, vol. 3, no. 3, article e85, 2005.
52. L. Maillet, C. Tu, Y. K. Hong, E. O. Shuster, and M. A. Collart, "The essential function of Not1 lies within the Ccr4-Not complex," Journal of Molecular Biology, vol. 303, no. 2, pp. 131-143, 2000.
53. J. Coller and R. Parker, "Eukaryotic mRNA decapping," Annual Review of Biochemistry, vol. 73, pp. 861-890, 2004.
54. P. A.Maroney, Y. Yu, J. Fisher, and T. W. Nilsen, "Evidence that microRNAs are associated with translatingmessenger RNAs in human cells," Nature Structural and Molecular Biology, vol. 13, no. 12, pp. 1102-1107, 2006.
55. J. A. Arribere, J. A. Doudna, and W. V. Gilbert, "Reconsidering movement of eukaryotic mRNAs between polysomes and P bodies," Molecular Cell, vol. 44, no. 5, pp. 745-758, 2011.
56. A. Mugge, U. Forstermann, and P. R. Lichtlen, "Endothelial functions in cardiovascular diseases," Zeitschrift für Kardiologie, vol. 78, no. 3, pp. 147-160, 1989.
57. B. G. Schwartz, C. Economides, G. S. Mayeda, S. Burstein, and R. A. Kloner, "The endothelial cell in health and disease: its function, dysfunction, measurement and therapy," International Journal of Impotence Research, vol. 22, no. 2, pp. 77-90, 2010.
58. E.-P. I. Chiang, S.-C. Chiu, M.-H. Pai et al., "Organosulfur garlic compounds induce neovasculogenesis in human endothelial progenitor cells through a modulation of MicroRNA 221 and the PI3-K/Akt signaling pathways," Journal of Agricultural and Food Chemistry, vol. 61, no. 20, pp. 4839-4849, 2013.
59. M. Duan, H. Yao, G. Hu, X. Chen, A. K. Lund, and S. Buch, "HIV Tat induces expression of ICAM-1 in HUVECs: implications for miR-221/-222 in HIV-associated cardiomyopathy," PLoS ONE, vol. 8, no. 3, Article IDe60170, 2013.
60. P. Dentelli, A. Rosso, F. Orso, C. Olgasi, D. Taverna, and M. F. Brizzi, "MicroRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 8, pp. 1562-1568, 2010.
61. M. T. Aye, S. Hashemi, B. Leclair et al., "Expression of stem cell factor and c-kit mRNA in cultured endothelial cells, monocytes and cloned human bone marrow stromal cells (CFU-RF)," Experimental Hematology, vol. 20, no. 4, pp. 523-527, 1992.
62. V. C. Broudy, N. L. Kovach, L. G. Bennett, N. Lin, F.W. Jacobsen, and P. G. Kidd, "Human umbilical vein endothelial cells display high-affinity c-kit receptors and produce a soluble form of the c-kit receptor," Blood, vol. 83, no. 8, pp. 2145-2152, 1994.
63. N. Felli, L. Fontana, E. Pelosi et al., "MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 50, pp. 18081-18086, 2005.
64. S.Nicoli, C.-P.Knyphausen, L. J. Zhu, A. Lakshmanan, and N.D. Lawson, "miR-221 is required for endothelial tip cell behaviors during vascular development," Developmental Cell, vol. 22, no. 2, pp. 418-429, 2012.
65. S. Nicoli, C. Standley, P. Walker, A. Hurlstone, K. E. Fogarty, and N. D. Lawson, "MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis," Nature, vol. 464, no. 7292, pp. 1196-1200, 2010.
66. K. Marcelo, T. Sills, S. Coskun et al., "Hemogenic endothelial cell specification requires c-Kit, notch signaling, and p27-mediated cell-cycle control," Developmental Cell, vol. 27, no. 5, pp. 504-515, 2013.
67. M. Graupera, J. Guillermet-Guibert, L. C. Foukas et al., "Angiogenesis selectively requires the p110α isoformof PI3K to control endothelial cell migration," Nature, vol. 453, no. 7195, pp. 662-666, 2008.
68. B. Vanhaesebroeck, J. Guillermet-Guibert, M. Graupera, and B. Bilanges, "The emerging mechanisms of isoform-specific PI3K signalling," Nature ReviewsMolecular Cell Biology, vol. 11, no. 5, pp. 329-341, 2010.
69. J. F. Wang, X. Zhang, and J. E. Groopman, "Activation of vascular endothelial growth factor receptor-3 and its downstream signaling promote cell survival under oxidative stress," Journal of Biological Chemistry, vol. 279, no. 26, pp. 27088-27097, 2004.
70. X. Zhang, H. Mao, J.-Y. Chen et al., "Increased expression of microRNA-221 inhibits PAK1 in endothelial progenitor cells and impairs its function via c-Raf/MEK/ERK pathway," Biochemical and Biophysical Research Communications, vol. 431, no. 3, pp. 404-408, 2013.
71. S. Zhang, J.Han, M. A. Sells et al., "Rho familyGTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1," Journal of Biological Chemistry, vol. 270, no. 41, pp. 23934-23936, 1995.
72. N. Soga, N. Namba, S. McAllister et al., "Rho family GTPases regulate VEGF-stimulated endothelial cell motility," Experimental Cell Research, vol. 269, no. 1, pp. 73-87, 2001.
73. B. H. Fryer, C. Wang, S. Vedantam et al., "cGMP-dependent protein kinase phosphorylates p21-activated kinase (Pak) 1, inhibiting Pak/Nck binding and stimulating Pak/vasodilatorstimulated phosphoprotein association," The Journal of Biological Chemistry, vol. 281, no. 17, pp. 11487-11495, 2006.
74. E. R. Park, S. T. Eblen, and A. D. Catling, "MEK1 activation by PAK: A novel mechanism," Cellular Signalling, vol. 19, no. 7, pp. 1488-1496, 2007.
75. M. Zang, C. Hayne, and Z. Luo, "Interaction between active Pak1 and Raf-1 is necessary for phosphorylation and activation of Raf-1," Journal of Biological Chemistry, vol. 277, no. 6, pp. 4395-4405, 2002.
76. Y. Chen, M. Banda, C. L. Speyer, J. S. Smith, A. B. Rabson, and D. H. Gorski, "Regulation of the expression and activity of the antiangiogenic homeobox gene GAX/MEOX2 by ZEB2 and MicroRNA-221," Molecular and Cellular Biology, vol. 30, no. 15, pp. 3902-3913, 2010.
77. A. Kuehbacher, C.Urbich, A. M. Zeiher, and S. Dimmeler, "Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis," Circulation Research, vol. 101, no. 1, pp. 59-68, 2007.
78. Y. Suárez, C. Fernández-Hernando, J. S. Pober, and W. C. Sessa, "Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells," Circulation Research, vol. 100, no. 8, pp. 1164-1173, 2007.
79. A. J. O'Hara, P. Chugh, L. Wang et al., "Pre-micro rna signatures delineate stages of endothelial cell transformation in kaposi sarcoma," PLoS Pathogens, vol. 5, no. 4, Article ID e1000389, 2009.
80. Y.-H. Wu, T.-F. Hu, Y.-C. Chen et al., "The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility," Blood, vol. 118, no. 10, pp. 2896-2905, 2011.
81. Y. Sato, K. Teruyama, T. Nakano et al., "Role of transcription factors in angiogenesis: Ets-1 promotes angiogenesis as well as endothelial apoptosis," Annals of the New York Academy of Sciences, vol. 947, pp. 117-123, 2001.
82. U. Förstermann and T. Münzel, "Endothelial nitric oxide synthase in vascular disease: from marvel to menace," Circulation, vol. 113, no. 13, pp. 1708-1714, 2006.
83. E. Sánchez-Tilló, L. Siles, O. de Barrios et al., "Expanding roles of ZEB factors in tumorigenesis and tumor progression," The American Journal of Cancer Research, vol. 1, no. 7, pp. 897-912, 2011.
84. D. H. Gorski and A. J. Leal, "Inhibition of endothelial cell activation by the homeobox gene Gax," Journal of Surgical Research, vol. 111, no. 1, pp. 91-99, 2003.
85. Y. Chen, A. D. Leal, S. Patel, and D. H. Gorski, "The homeobox gene GAX activates p21WAF1/CIP1 expression in vascular endothelial cells through direct interaction with upstream ATrich sequences," Journal of Biological Chemistry, vol. 282, no. 1, pp. 507-517, 2007.
86. S. Patel, A. D. Leal, and D. H. Gorski, "The homeobox gene Gax inhibits angiogenesis through inhibition of nuclear factor-κBdependent endothelial cell gene expression," Cancer Research, vol. 65, no. 4, pp. 1414-1424, 2005.
87. X. Yang, D. Qiao, K. Meyer, and A. Friedl, "Signal transducers and activators of transcriptionmediate fibroblast growth factorinduced vascular endothelial morphogenesis," Cancer Research, vol. 69, no. 4, pp. 1668-1677, 2009.
88. X. Yang, D. Qiao, K. Meyer, T. Pier, S. Keles, and A. Friedl, "Angiogenesis induced by signal transducer and activator of transcription 5A (STAT5A) is dependent on autocrine activity of proliferin,"The Journal of Biological Chemistry, vol. 287, no. 9, pp. 6490-6502, 2012.
89. X. Yang, K. Meyer, and A. Friedl, "STAT5 and prolactin participate in a positive autocrine feedback loop that promotes angiogenesis," Journal of Biological Chemistry, vol. 288, no. 29, pp. 21184-21196, 2013.
90. P. Dentelli, L. del Sorbo, A. Rosso et al., "Human IL-3 stimulates endothelial cell motility and promotes in vivo new vessel formation," The Journal of Immunology, vol. 163, no. 4, pp. 2151-2159, 1999.
91. M.-T. Park, E.-T. Oh, M.-J. Song, H. Lee, and H. J. Park, "Radiosensitivities and angiogenic signaling pathways of irradiated normal endothelial cells derived from diverse human organs," Journal of Radiation Research, vol. 53, no. 4, pp. 570-580, 2012.
92. S. Vincenti, N. Brillante, V. Lanza et al., "HUVEC respond to radiation by inducing the expression of pro-angiogenicMicroRNAs," Radiation Research, vol. 175, no. 5, pp. 535-546, 2011.
93. H. Dellago, B. Preschitz-Kammerhofer, L. Terlecki-Zaniewicz et al., "High levels of oncomiR-21 contribute to the senescenceinduced growth arrest in normal human cells and its knockdown increases the replicative lifespan," Aging Cell, vol. 12, no. 3, pp. 446-458, 2013.
94. J. M. Yu, X. Wu, J. M. Gimble, X. Guan, M. A. Freitas, and B. A. Bunnell, "Age-related changes in mesenchymal stem cells derived fromrhesusmacaque bone marrow," Aging Cell, vol. 10, no. 1, pp. 66-79, 2011.
95. N. N. Hooten, K. Abdelmohsen, M. Gorospe, N. Ejiogu, A. B. Zonderman, and M. K. Evans, "microRNA expression patterns reveal differential expression of target genes with age," PLoS ONE, vol. 5, no. 5, Article ID e10724, 2010.
96. K. Sobue, K. Hayashi, and W. Nishida, "Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation," Molecular and Cellular Biochemistry, vol. 190, no. 1-2, pp. 105-118, 1999.
97. K. Kawai-Kowase and G. K. Owens, "Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells," American Journal of Physiology: Cell Physiology, vol. 292, no. 1, pp. C59-C69, 2007.
98. C. Purcell, M. Tennant, and J. McGeachie, "Neo-intimal hyperplasia in vascular grafts and its implications for autologous arterial grafting," Annals of the Royal College of Surgeons of England, vol. 79, no. 3, pp. 164-168, 1997.
99. G. K. Owens, "Molecular control of vascular smoothmuscle cell differentiation and phenotypic plasticity," Novartis Foundation Symposia, vol. 283, pp. 174-191, 2007.
100. V. R. Babaev, Y. V. Bobryshev, O. V. Stenina, E. M. Tararak, and G. Gabbiani, "Heterogeneity of smooth muscle cells in atheromatous plaque of human aorta," The American Journal of Pathology, vol. 136, no. 5, pp. 1031-1042, 1990.
101. V. R. Babaev, Y. V. Bobryshev, G. K. Sukhova, and I. A. Kasantseva, "Monocyte/macrophage accumulation and smooth muscle cell phenotypes in early atherosclerotic lesions of human aorta," Atherosclerosis, vol. 100, no. 2, pp. 237-248, 1993.
102. X. Liu, Y. Cheng, J. Yang, L. Xu, and C. Zhang, "Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application," Journal of Molecular and Cellular Cardiology, vol. 52, no. 1, pp. 245-255, 2012.
103. X. Liu, Y. Cheng, S. Zhang, Y. Lin, J. Yang, and C. Zhang, "Anecessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia," Circulation Research, vol. 104, no. 4, pp. 476-486, 2009.
104. C. A. McNamara, I. J. Sarembock, B. G. Bachhuber et al., "Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis," Seminars in Thrombosis and Hemostasis, vol. 22, no. 2, pp. 139-144, 1996.
105. P. Castagnino, D. Kothapalli, E. A. Hawthorne et al., "miR-221/ 222 compensates for skp2-mediated p27 degradation and is a primary target of cell cycle regulation by prostacyclin and cAMP," PLoS ONE, vol. 8, no. 2, Article ID e56140, 2013.
106. C. A. Auld, K. M. Fernandes, and R. F. Morrison, "Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia," Journal of Cellular Physiology, vol. 211, no. 1, pp. 101-111, 2007.
107. S. Matsuoka, M. C. Edwards, C. Bai et al., "P57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene," Genes & Development, vol. 9, no. 6, pp. 650-662, 1995.
108. E. G. Reynaud, M. P. Leibovitch, L. A. J. Tintignac, K. Pelpel, M. Guillier, and S. A. Leibovitch, "Stabilization of MyoD by direct binding to p57Kip2,"The Journal of Biological Chemistry, vol. 275, no. 25, pp. 18767-18776, 2000.
109. Z. Wang, D.-Z. Wang, G. C. T. Pipes, and E. N. Olson, "Myocardin is a master regulator of smooth muscle gene expression," Proceedings of the National Academy of Sciences of theUnited States ofAmerica, vol. 100, no. 12, pp.7129-7134,2003.
110. P. F. Davies, "Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology," Nature Clinical Practice Cardiovascular Medicine, vol. 6, no. 1, pp. 16-26, 2009.
111. A. G. Passerini, D. C. Polacek, C. Shi et al., "Coexisting proinflammatory and antioxidative endothelial transcription profiles in a disturbed flow region of the adult porcine aorta," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 8, pp. 2482-2487, 2004.
112. A. R. Brooks, P. I. Lelkes, and G. M. Rubanyi, "Gene expression profiling of vascular endothelial cells exposed to fluid mechanical forces: relevance for focal susceptibility to atherosclerosis," Endothelium, vol. 11, no. 1, pp. 45-57, 2004.
113. E. J. R. Mattsson, T. R. Kohler, S. M. Vergel, and A. W. Clowes, "Increased blood flow induces regression of intimal hyperplasia," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 10, pp. 2245-2249, 1997.
114. T. M. Griffith, "Endothelial control of vascular tone by nitric oxide and gap junctions: a haemodynamic perspective," Biorheology, vol. 39, no. 3-4, pp. 307-318, 2002.
115. C. Cheng, R. van Haperen, M. de Waard et al., "Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique," Blood, vol. 106, no. 12, pp. 3691-3698, 2005.
116. C. Cheng, D. Tempel, R. van Haperen et al., "Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress," Circulation, vol. 113, no. 23, pp. 2744-2753, 2006.
117. G. Dai, M. R. Kaazempur-Mofrad, S. Natarajan et al., "Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 41, pp. 14871-14876, 2004.
118. J. Suo, D. E. Ferrara, D. Sorescu, R. E. Guldberg, W. R. Taylor, and D. P. Giddens, "Hemodynamic shear stresses in mouse aortas: implications for atherogenesis," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 2, pp. 346-351, 2007.
119. L. Rouleau, J. Rossi, and R. L. Leask, "The response of human aortic endothelial cells in a stenotic hemodynamic environment: effect of duration, magnitude, and spatial gradients in wall shear stress," Journal of Biomechanical Engineering, vol. 132, no. 7, Article ID071015, 2010.
120. G. Dai, S. Vaughn, Y. Zhang, E. T. Wang, G. Garcia-Cardena, and M. A. Gimbrone Jr., "Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2," Circulation Research, vol. 101, no. 7, pp. 723-733, 2007.
121. Y. Fang, C. Shi, E. Manduchi, M. Civelek, and P. F. Davies, "MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 30, pp. 13450-13455, 2010.
122. Y. Fang and P. F.Davies, "Site-specific microRNA-92a regulation of Krüppel-like factors 4 and 2 in atherosusceptible endothelium," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 4, pp. 979-987, 2012.
123. C.-Y. Hsieh, H.-Y. Hsiao, W.-Y.Wu et al., "Regulation of shearinduced nuclear translocation of the Nrf2 transcription factor in endothelial cells," Journal of Biomedical Science, vol. 16, no. 1, article 12, 2009.
124. X. L. Chen, G. Dodd, S.Thomas et al., "Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 290, no. 5, pp. H1862-H1870, 2006.
125. J. Y. Moon, "Recent update of renin-angiotensin-aldosterone system in the pathogenesis of hypertension," Electrolytes & Blood Pressure, vol. 11, no. 2, pp. 41-45, 2013.
126. Y.-T. Wang, P.-C. Tsai, Y.-C. Liao, C.-Y. Hsu, and S.-H. H. Juo, "Circulating microRNAs have a sex-specific association with metabolic syndrome," Journal of Biomedical Science, vol. 20, no. 1, article 72, 2013.
127. I. Jovanović, M. Zivković, J. Jovanović, T. Djurić, and A. Stanković, "The co-inertia approach in identification of specific microRNA in early and advanced atherosclerosis plaque," Medical Hypotheses, vol. 83, no. 1, pp. 11-15, 2014.
128. Y. V. Bobryshev, "Monocyte recruitment and foam cell formation in atherosclerosis," Micron, vol. 37, no. 3, pp. 208-222, 2006.
129. A.-Y. Gong, G. Hu, R. Zhou et al., "MicroRNA-221 controls expression of intercellular adhesion molecule-1 in epithelial cells in response to Cryptosporidium parvum infection," International Journal for Parasitology, vol. 41, no. 3-4, pp. 397-403, 2011.
130. Q. Zhang, I. Kandic, and M. J. Kutryk, "Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease," Biochemical and Biophysical Research Communications, vol. 405, no. 1, pp. 42-46, 2011.
131. Y. Minami, M. Satoh, C. Maesawa et al., "Effect of atorvastatin on microRNA221/222 expression in endothelial progenitor cells obtained from patients with coronary artery disease," European Journal of Clinical Investigation, vol. 39, no. 5, pp. 359-367, 2009.
132. G. Togliatto, A. Trombetta, P. Dentelli, A. Rosso, and M. F. Brizzi, "MIR221/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucose-and AGE-mediated vascular cell damage," Diabetologia, vol. 54, no. 7, pp. 1930-1940, 2011.
133. C. B. Coleman, D. J. Lightell, S. C.Moss, M. Bates, P. E. Parrino, and T. C.Woods, "Elevation of miR-221 and -222 in the internal mammary arteries of diabetic subjects and normalization with metformin,"Molecular and Cellular Endocrinology, vol. 374, no. 1-2, pp. 125-129, 2013.
134. T. Li, H. Cao, J. Zhuang et al., "Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans," Clinica Chimica Acta, vol. 412, no. 1-2, pp. 66-70, 2011.
135. X. Zhang, S. Shao, H. Geng et al., "Expression profiles of six circulating microRNAs critical to atherosclerosis in patients with subclinical hypothyroidism: a clinical study," Journal of Clinical Endocrinology andMetabolism, vol. 99, no. 5, pp. E766-E774, 2014.
136. D. A. Chistiakov, I. A. Sobenin, and A. N. Orekhov, "Vascular extracellular matrix in atherosclerosis," Cardiology in Review, vol. 21, no. 6, pp. 270-288, 2013.
137. G. Hu, A.-Y. Gong, J. Liu, R. Zhou, C. Deng, and X.-M. Chen, "miR-221 suppresses ICAM-1 translation and regulates interferon-γ-induced ICAM-1 expression in human cholangiocytes," American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 298, no. 4, pp. G542-G550, 2010.
138. S. Mardente, E. Mari, F. Consorti et al., "HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth andmotility in papillary thyroid cancer cells," Oncology Reports, vol. 28, no. 6, pp. 2285-2289, 2012.
139. Y. Luo, S.-J. Li, J. Yang, Y.-Z. Qiu, and F.-P. Chen, "HMGB1 induces an inflammatory response in endothelial cells via the RAGE-dependent endoplasmic reticulum stress pathway," Biochemical and Biophysical Research Communications, vol. 438, no. 4, pp. 732-738, 2013.
140. G. H. Gibbons, R. E. Pratt, and V. J. Dzau, "Vascular smooth muscle cell hypertrophy vs. hyperplasia: autocrine transforming growth factor-β, expression determines growth response to angiotensin II," Journal of Clinical Investigation, vol. 90, no. 2, pp. 456-461, 1992.
141. P. K. Mehta and K. K. Griendling, "Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system,"The American Journal of Physiology-Cell Physiology, vol. 292, no. 1, pp. C82-C97, 2007.
142. X. Dong, L.-G. Yu, R. Sun et al., "Inhibition of PTEN expression and activity by angiotensin II induces proliferation and migration of vascular smooth muscle cells," Journal of Cellular Biochemistry, vol. 114, no. 1, pp. 174-182, 2013.
143. J. Andrae, R. Gallini, and C. Betsholtz, "Role of plateletderived growth factors in physiology and medicine," Genes and Development, vol. 22, no. 10, pp. 1276-1312, 2008.
144. A. Díez-Juan and V. Andrés, "The growth suppressor p27Kip1 protects against diet-induced atherosclerosis," FASEB Journal, vol. 15, no. 11, pp. 1989-1995, 2001.
145. L. M. Akyürek, M. Boehm, M. Olive, A.-X. Zhou, H. San, and E. G. Nabel, "Deficiency of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1 accelerates atherogenesis in apolipoprotein E-deficient mice," Biochemical and Biophysical Research Communications, vol. 396, no. 2, pp. 359-363, 2010.
146. D.Kothapalli, P. Castagnino, D. J. Rader, M. C. Phillips, S. Lund-Katz, and R. K. Assoian, "Apolipoprotein E-mediated cell cycle arrest linked to p27 and the Cox2-dependent repression of miR221/222," Atherosclerosis, vol. 227, no. 1, pp. 65-71, 2013.
147. M. Ishigami, D. K. Swertfeger, M. S. Hui, N. A. Granholm, and D. Y. Hui, "Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 4, pp. 1020-1026, 2000.
148. L. Paka, I. J. Goldberg, J. C. Obunike et al., "Perlecan mediates the antiproliferative effect of apolipoprotein E on smooth muscle cells. An underlying mechanism for the modulation of smooth muscle cell growth?" The Journal of Biological Chemistry, vol. 274, no. 51, pp. 36403-36408, 1999.
149. F. C. Tanner, M. Boehm, L. M. Akyürek et al., "Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1) and p16(Ink4) on vascular smooth muscle cell proliferation," Circulation, vol. 101, no. 17, pp. 2022-2025, 2000.
150. N. Nakano, K. Urasawa, Y. Takagi et al., "Downregulation of cyclin-dependent kinase inhibitor; p57kip2, is involved in the cell cycle progression of vascular smooth muscle cells," Biochemical and Biophysical Research Communications, vol. 338, no. 3, pp. 1661-1667, 2005.
151. N. Mackenzie, D. Zhu, P. Genever, and V. MacRae, "The miR-221/222 family regulates vascular smooth muscle cell calcification," Bone Abstracts, vol. 1, article PP496, 2013.
152. Y. V. Bobryshev, "Targeting vascular calcification: up-date," Current Pharmaceutical Design, vol. 20, no. 37, p. 5799, 2014.
153. Y. V. Bobryshev, R. S. A. Lord, and B. A. Warren, "Calcified deposit formation in intimal thickenings of the human aorta," Atherosclerosis, vol. 118, no. 1, pp. 9-21, 1995.
154. N. Niederhoffer, Y. V. Bobryshev, I. Lartaud-Idjouadiene, P. Giummelly, and J. Atkinson, "Aortic calcification produced by vitamin D3 plus nicotine," Journal of Vascular Research, vol. 34, no. 5, pp. 386-398, 1997.
155. D. A. Chistiakov, I. A. Sobenin, A. N. Orekhov, and Y. V. Bobryshev, "Mechanisms of medial arterial calcification in diabetes," Current Pharmaceutical Design, vol. 20, no. 37, pp. 5870-5883, 2014.
156. Y. V. Bobryshev, "Transdifferentiation of smooth muscle cells into chondrocytes in atherosclerotic arteries in situ: implications for diffuse intimal calcification," Journal of Pathology, vol. 205, no. 5, pp. 641-650, 2005.
157. R. Villa-Bellosta, X. Wang, J. L. Millán, G. R. Dubyak, and W. C. O'Neill, "Extracellular pyrophosphate metabolism and calcification in vascular smooth muscle," American Journal of Physiology: Heart and Circulatory Physiology, vol. 301, no. 1, pp. H61-H68, 2011.
158. T. Li, H. Cao, J. Zhuang et al., "Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans," Clinica Chimica Acta, vol. 412, no. 1-2, pp. 66-70, 2011.
159. Y. V. Bobryshev, "Dendritic cells in atherosclerosis: current status of the problem and clinical relevance," European Heart Journal, vol. 26, no. 17, pp. 1700-1704, 2005.
160. K. J. Woollard, "Immunological aspects of atherosclerosis," Clinical Science, vol. 125, no. 5, pp. 221-235, 2013.
161. D. A. Chistiakov, I. A. Sobenin, A. N. Orekhov, and Y. V. Bobryshev, "Dendritic cells: a double-edge sword in atherosclerotic inflammation," Atherosclerosis, 2013.
162. H. Ait-Oufella, A. P. Sage, Z. Mallat, and A. Tedgui, "Adaptive (T and B Cells) immunity and control by dendritic cells in atherosclerosis," Circulation Research, vol. 114, no. 10, pp. 1640-1660, 2014.
163. C. Lu, X. Huang, X. Zhang et al., "miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27 kip1, KPC1, and SOCS-1," Blood, vol. 117, no. 16, pp. 4293-4303, 2011.
164. H. Kuipers, F. M. Schnorfeil, and T. Brocker, "Differentially expressed microRNAs regulate plasmacytoid vs. conventional dendritic cell development,"Molecular Immunology, vol. 48, no. 1-3, pp. 333-340, 2010.
165. S.Montagner, E.M. Orlandi, S.Merante, andS.Monticelli, "The role of miRNAs in mast cells and other innate immune cells," Immunological Reviews, vol. 253, no. 1, pp. 12-24, 2013.
166. B. S. Nielsen and K. Holmstrom, "Combined microRNA in situ hybridization and immunohistochemical detection of protein markers," Methods in Molecular Biology, vol. 986, pp. 353-365, 2013.
167. M. Schneider, D. C. Andersen, A. Silahtaroglu et al., "Cellspecific detection of microRNA expression during cardiomyogenesis by combined in situ hybridization and immunohistochemistry," Journal of Molecular Histology, vol. 42, no. 4, pp. 289-299, 2011.
168. A. D. Chaudhuri, S. V. Yelamanchili, and H. S. Fox, "Combined fluorescent in situ hybridization for detection of microRNAs and immunofluorescent labeling for cell-type markers," Frontiers in Cellular Neuroscience, vol. 7, article 160, 2013.
169. Y. V. Bobryshev, "Intracellular localization of oxidized lowdensity lipoproteins in atherosclerotic plaque cells revealed by electron microscopy combined with laser capture microdissection," Journal of Histochemistry and Cytochemistry, vol. 53, no. 6, pp. 793-797, 2005.
170. J. E. Feig and E. A. Fisher, "Laser capture microdissection for analysis of macrophage gene expression from atherosclerotic lesions," Methods in Molecular Biology, vol. 1027, pp. 123-135, 2013.
171. R.Malgor, P. M. Bhatt, B. A. Connolly et al., "Wnt5a, TLR2 and TLR4 are elevated in advanced human atherosclerotic lesions," Inflammation Research, vol. 63, no. 4, pp. 277-285, 2014.
172. A. Meerson, M. Traurig, V. Ossowski, J. M. Fleming, M. Mullins, and L. J. Baier, "Human adipose microRNA-221 is upregulated in obesity and affects fat metabolism downstream of leptin and TNF-α," Diabetologia, vol. 56, no. 9, pp. 1971-1979, 2013.
173. Y. Lustig, E. Barhod, R. Ashwal-Fluss et al., "RNA-binding protein PTB and MicroRNA-221 coregulate AdipoR1 translation and adiponectin signaling," Diabetes, vol. 63, no. 2, pp. 433-445, 2014.
174. J. Nedvídková, K. Smitka, V. Kopský, and V. Hainer, "Adiponectin, an adipocyte-derived protein," Physiological Research, vol. 54, no. 2, pp. 133-140, 2005.
175. P. Zhang, Y. Wang, Y. Fan, Z. Tang, and N. Wang, "Overexpression of adiponectin receptors potentiates the antiinflammatory action of subeffective dose of globular adiponectin in vascular endothelial cells," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 1, pp. 67-74, 2009.
176. W.-W. Chou, Y.-T. Wang, Y.-C. Liao, S.-C. Chuang, S.-N. Wang, and S.-H. H. Juo, "Decreased MicroRNA-221 is associated with high levels of TNF-α in human adipose tissue-derived mesenchymal stem cells from obese woman," Cellular Physiology and Biochemistry, vol. 32, no. 1, pp. 127-137, 2013.
177. F. J. Ortega, J. M. Mercader, V. Catalán et al., "Targeting the circulating microRNA signature of obesity," Clinical Chemistry, vol. 59, no. 5, pp. 781-792, 2013.
178. J. Berndt, P. Kovacs, K. Ruschke et al., "Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetes," Diabetologia, vol. 50, no. 7, pp. 1472-1480, 2007.
179. C. Capurso and A. Capurso, "From excess adiposity to insulin resistance: the role of free fatty acids," Vascular Pharmacology, vol. 57, no. 2-4, pp. 91-97, 2012.
180. G. Togliatto, A. Trombetta, P. Dentelli et al., "Unacylated ghrelin promotes skeletal muscle regeneration following hindlimb ischemia via SOD-2-mediated miR-221/222 expression," Journal of the American Heart Association, vol. 2, no. 6, Article ID e000376, 2013.
181. J. A. Ward, N. Esa, R. Pidikiti et al., "Circulating cell and plasma microRNA profiles differ between non-ST-segment and STsegment-elevation myocardial infarction," Family Medicine & Medical Science Research, vol. 2, no. 2, article 108, 2013.
182. B. Cardinalli, L. Castellani, P. Fasanaro et al., "Microrna-221 and microrna-222 modulate differentiation and maturation of skeletalmuscle cells," PLoS ONE, vol. 4, no. 10, Article IDe7607, 2009.
183. M. W. Hamrick, S. Herberg, P. Arounleut et al., "The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice," Biochemical and Biophysical Research Communications, vol. 400, no. 3, pp. 379-383, 2010.
184. A. P. D. Andreote, M. F. Rosario, M.C. Ledur et al., "Identification and characterization of microRNAs expressed in chicken skeletal muscle," Genetics and Molecular Research, vol. 13, no. 1, pp. 1465-1479, 2014.
185. S. Greco, A. Perfetti, P. Fasanaro et al., "Deregulated microRNAs in myotonic dystrophy type 2," PLoS ONE, vol. 7, no. 6, Article ID e39732, 2012.
186. H. J. Feng, W. Ouyang, J. H. Liu et al., "Global microRNA profiles and signaling pathways in the development of cardiac hypertrophy," Brazilian Journal of Medical and Biological Research, vol. 47, no. 5, pp. 361-368, 2014.
187. S. Hu, M. Huang, P. K. Nguyen et al., "Novel MicroRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation," Circulation, vol. 124, no. 11, pp. S27-S34, 2011.
188. B. Yu, M. Gong, Y. Wang et al., "Cardiomyocyte protection by GATA-4 gene engineered mesenchymal stem cells is partially mediated by translocation of miR-221 in microvesicles," PLoS ONE, vol. 8, no. 8, Article ID e73304, 2013.
189. X. Zhou, P. Yuan, and Y. He, "Role of microRNAs in peripheral artery disease," Molecular Medicine Reports, vol. 6, no. 4, pp. 695-700, 2012.
190. D. A. Chistiakov, I. A. Sobenin, and A. N. Orekhov, "Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology," Drug Delivery, vol. 19, no. 8, pp. 392-405, 2012.
191. C. Fernández-Hernando and A. Baldán, "MicroRNAs and cardiovascular disease," Current Genetic Medicine Reports, vol. 1, no. 1, pp. 30-38, 2013.
192. T. Imanishi and T. Akasaka, "MicroRNAs in peripheral artery disease," Current Topics in Medicinal Chemistry, vol. 13, no. 13, pp. 1589-1595, 2013.
193. H. Toba, D. Cortez, M. L. Lindsey, and R. J. Chilton, "Applications of miRNA technology for atherosclerosis," Current Atherosclerosis Reports, vol. 16, no. 2, ar, 2014.
194. X. Lu and V. Kakkar, "The roles of microRNAs in atherosclerosis," Current Medicinal Chemistry, vol. 21, no. 13, pp. 1531-1543, 2014.
195. L. Gramantieri, F. Fornari, E. Callegari et al., "MicroRNA involvement in hepatocellular carcinoma: microRNA review series," Journal of Cellular and Molecular Medicine, vol. 12, no. 6A, pp. 2189-2204, 2008.
196. R. Nassirpour, P. P. Mehta, S. M. Baxi, and M. J. Yin, "miR-221 promotes tumorigenesis in human triple negative breast cancer cells," PLoS ONE, vol. 8, no. 4, Article ID e62170, 2013.
197. Q. Lin, W. Mao, Y. Shu et al., "A cluster of specified microRNAs in peripheral blood as biomarkers formetastatic non-small-cell lung cancer by stem-loop RT-PCR," Journal of Cancer Research and Clinical Oncology, vol. 138, no. 1, pp. 85-93, 2012.
198. K. Sun, W. Wang, J.-J. Zeng, C.-T. Wu, S.-T. Lei, and G.-X. Li, "MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma," Acta Pharmacologica Sinica, vol. 32, no. 3, pp. 375-384, 2011.
199. Y.-K. Kim, J. Yu, T. S. Han et al., "Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer," Nucleic Acids Research, vol. 37, no. 5, pp. 1672-1681, 2009.
200. S. Sarkar, H. Dubaybo, S. Ali et al., "Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA," American Journal of Cancer Research, vol. 3, no. 5, pp. 465-477, 2013.
201. E. N. Howe, D.R. Cochrane, and J.K. Richer, "ThemiR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity," Journal ofMammary Gland Biology and Neoplasia, vol. 17, no. 1, pp. 65-77, 2012.
202. Y.-L. Fan, M. Zheng, Y.-L. Tang, and X.-H. Liang, "A new perspective of vasculogenic mimicry: EMT and cancer stem cells," Oncology Letters, vol. 6, no. 5, pp. 1174-1180, 2013.
203. J. Du, B. Sun, X. Zhao et al., "Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma," Gynecologic Oncology, vol. 133, no. 3, pp. 575-583, 2014.
204. S. M. Ehsan, K. M. Welch-Reardon, M. L. Waterman, C. C.W. Hughes, and S. C. George, "A three-dimensional in vitro model of tumor cell intravasation," Integrative Biology (United Kingdom), vol. 6, no. 6, pp. 603-610, 2014.